(Q38815964)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Susana Miranda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Shahneen K Sandhu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Mateus Crespo

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Pasquale Rescigno

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Adam Sharp

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Christopher J Lord

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Emma Hall

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Suzanne Carreira

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Johann de Bono

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1

Jane Goodall

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

2

Joaquin Mateo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

28

Diletta Bianchini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

13

Penny Flohr

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

23

Semini Sumanasuriya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

11

Gemma Fowler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

12

Berni Ebbs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

Claudia Maria Bertan Membrive

19 March 2020

17

object named as

Claudia Bertan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

22

Ruth Riisnaes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Daniel Nava Rodrigues

15

object named as

Daniel Nava Rodrigues

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

16

Gunther Boysen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

25

Zafeiris Zafeiriou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

8

David Dolling

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

27

Nina Tunariu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

7

Raquel Perez-Lopez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

9

Dan R Robinson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Wei Yuan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Nuria Porta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

George Seed

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Mark Atkin

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Matthew Clarke

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Ines Figueiredo

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Alexa Gillman

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Arul M Chinnaiyan

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

TOPARP-A investigators

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

1 reference

27 April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

1006-1017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

Commentary on "Integrative clinical genomics of advanced prostate cancer". Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P,

19 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer.

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer.

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

The Molecular Taxonomy of Primary Prostate Cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Plasma AR and abiraterone-resistant prostate cancer.

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Spatial genomic heterogeneity within localized, multifocal prostate cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

The evolutionary history of lethal metastatic prostate cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Tumor clone dynamics in lethal prostate cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

The mutational landscape of lethal castration-resistant prostate cancer

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Detection of mutations in EGFR in circulating lung-cancer cells

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Resistance to therapy caused by intragenic deletion in BRCA2

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

BRCA2 is required for homology-directed repair of chromosomal breaks

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Secondary mutations inBRCA2associated with clinical resistance to a PARP inhibitor

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6143169

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

3 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28450425

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/2159-8290.CD-17-0261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28450425%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

PubMed publication ID

28450425

1 reference